Global Oral Vaccines Competitive Landscape Professional Research Report 2025

Global Oral Vaccines Competitive Landscape Professional Research Report 2025

Research Summary

Oral vaccines are a type of immunization that is administered through the oral route, typically in the form of a liquid or tablet. Unlike traditional vaccines, which are injected, oral vaccines are designed to stimulate an immune response in the gastrointestinal system. They often contain weakened or inactivated forms of the pathogen, allowing the body to develop immunity without causing the disease. Oral vaccines are a valuable tool in public health, as they can be administered without the need for needles or trained healthcare professionals, making them suitable for mass vaccination campaigns. They have been successfully used to protect against diseases such as polio, cholera, and rotavirus, and ongoing research is exploring their potential for other infectious diseases. Oral vaccines offer several advantages, including ease of administration, reduced risk of infection, and potential for widespread distribution, particularly in areas with limited access to healthcare facilities.

According to DIResearch's in-depth investigation and research, the global Oral Vaccines market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Serum Institute, Lanzhou Institute, Valneva, Shanghai United Cell, Vabiotech, PaxVax, Bibcol, Tiantan Biological, EuBiologics, Panacea Biotec, Bio-Med, Halfkin Bio-Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Oral Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Oral Vaccines Include:

Merck

GSK

Sanofi

Serum Institute

Lanzhou Institute

Valneva

Shanghai United Cell

Vabiotech

PaxVax

Bibcol

Tiantan Biological

EuBiologics

Panacea Biotec

Bio-Med

Halfkin Bio-Pharmaceuticals

Oral Vaccines Product Segment Include:

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Oral Vaccines Product Application Include:

Adult

Child

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Oral Vaccines Industry PESTEL Analysis

Chapter 3: Global Oral Vaccines Industry Porter’s Five Forces Analysis

Chapter 4: Global Oral Vaccines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Oral Vaccines Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Oral Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Oral Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Oral Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Oral Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Oral Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Oral Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Oral Vaccines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources